Duraflo II coating of cardiopulmonary bypass circuits reduces complement activation, but does not affect the release of granulocyte enzymes in fully heparinized patients: a European multicentre study

This publication has 24 references indexed in Scilit:

• Specific complement inhibition with heparin-coated extracorporeal circuits
  The Annals of Thoracic Surgery, 1996
• Complement and granulocyte activation in two different types of heparinized extracorporeal circuits
  The Journal of Thoracic and Cardiovascular Surgery, 1995
• Reduced complement activation and improved postoperative performance after cardiopulmonary bypass with heparin-coated circuits
  Published by Elsevier ,1995
• Complement activation during cardiopulmonary bypass: Effects of immobilized heparin
  The Annals of Thoracic Surgery, 1994
• Reduced Granulocyte Activation with a Heparin–Coated Device in an In Vitro Model of Cardiopulmonary Bypass
  Artificial Organs, 1991
• Analysis of serial measurements in medical research.
  BMJ, 1990
• Inflammatory System Activation During Cardiopulmonary Bypass as an Indicator of Biocompatibility: A Randomized Comparison of Bubble and Membrane Oxygenators
  Scandinavian Journal of Thoracic and Cardiovascular Surgery, 1990
• Serum and plasma measurements of neutrophil granule proteins during cardiopulmonary bypass: A model to estimate human turnover of lactoferrin and myeloperoxidase
  European Journal of Haematology, 1987
• Quantification of the Terminal Complement Complex in Human Plasma by an Enzyme‐Linked Immunosorbent Assay Based on Monoclonal Antibodies against a Neoantigen of the Complex
  Scandinavian Journal of Immunology, 1985
• Effects of Serum and Cations on the Selective Release of Granular Proteins from Human Neutrophils during Phagocytosis
  Scandinavian Journal of Haematology, 1979